Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	POLA1 CARS1 SLU7 MCM7 XRCC4 TRMT2B IFIH1 PPP1R8 SUPV3L1 RECQL5 XRN1 POLN ASCC3 DDX24 TARBP1 DDX39B TOP3A	2.11e-06	645	137	17	GO:0140640
GeneOntologyMolecularFunction	ATP hydrolysis activity	KIF18A DNAH3 PSMC4 RNF213 MCM7 ATP8B2 IFIH1 SUPV3L1 RECQL5 ASCC3 DDX24 DNAH5 DDX39B DYNC1H1	2.14e-06	441	137	14	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity	KIF18A DNAH3 MYO5A MYO1H PSMC4 RNF213 MCM7 ATP8B2 IFIH1 SUPV3L1 RECQL5 ASCC3 DDX24 DNAH5 DDX39B DYNC1H1	4.97e-06	614	137	16	GO:0140657
GeneOntologyMolecularFunction	store-operated calcium channel activity	TRPC7 TRPC3 TRPC6	6.64e-05	12	137	3	GO:0015279
GeneOntologyMolecularFunction	inositol 1,4,5 trisphosphate binding	TRPC7 TRPC3 TRPC6	1.09e-04	14	137	3	GO:0070679
GeneOntologyMolecularFunction	helicase activity	MCM7 IFIH1 SUPV3L1 RECQL5 ASCC3 DDX24 DDX39B	1.11e-04	158	137	7	GO:0004386
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNAH3 DYNLL1 DNAH5 DYNC1H1	1.17e-04	37	137	4	GO:0045505
GeneOntologyMolecularFunction	glycogen phosphorylase activity	PYGB PYGM	1.40e-04	3	137	2	GO:0008184
GeneOntologyMolecularFunction	cytoskeletal motor activity	KIF18A DNAH3 MYO5A MYO1H DNAH5 DYNC1H1	1.64e-04	118	137	6	GO:0003774
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH3 DNAH5 DYNC1H1	2.39e-04	18	137	3	GO:0008569
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	KIF18A DNAH3 PSMC4 RNF213 MCM7 ATP8B2 IFIH1 SUPV3L1 RECQL5 GNL2 ASCC3 DDX24 DNAH5 DDX39B DYNC1H1	2.85e-04	775	137	15	GO:0017111
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	POLA1 MCM7 XRCC4 SUPV3L1 RECQL5 POLN ASCC3 TOP3A	4.60e-04	262	137	8	GO:0140097
GeneOntologyMolecularFunction	1,4-alpha-oligoglucan phosphorylase activity	PYGB PYGM	4.61e-04	5	137	2	GO:0004645
GeneOntologyMolecularFunction	cytoskeleton-nuclear membrane anchor activity	SYNE1 SYNE2	4.61e-04	5	137	2	GO:0140444
GeneOntologyMolecularFunction	catalytic activity, acting on RNA	CARS1 SLU7 TRMT2B IFIH1 PPP1R8 SUPV3L1 XRN1 DDX24 TARBP1 DDX39B	6.16e-04	417	137	10	GO:0140098
GeneOntologyMolecularFunction	pyrophosphatase activity	KIF18A DNAH3 PSMC4 RNF213 MCM7 ATP8B2 IFIH1 SUPV3L1 RECQL5 GNL2 ASCC3 DDX24 DNAH5 DDX39B DYNC1H1	6.53e-04	839	137	15	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	KIF18A DNAH3 PSMC4 RNF213 MCM7 ATP8B2 IFIH1 SUPV3L1 RECQL5 GNL2 ASCC3 DDX24 DNAH5 DDX39B DYNC1H1	6.61e-04	840	137	15	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	KIF18A DNAH3 PSMC4 RNF213 MCM7 ATP8B2 IFIH1 SUPV3L1 RECQL5 GNL2 ASCC3 DDX24 DNAH5 DDX39B DYNC1H1	6.61e-04	840	137	15	GO:0016818
GeneOntologyMolecularFunction	DNA helicase activity	MCM7 SUPV3L1 RECQL5 ASCC3	8.69e-04	62	137	4	GO:0003678
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH3 DNAH5 DYNC1H1	9.13e-04	28	137	3	GO:0051959
GeneOntologyMolecularFunction	microtubule motor activity	KIF18A DNAH3 DNAH5 DYNC1H1	1.37e-03	70	137	4	GO:0003777
GeneOntologyMolecularFunction	calcium channel activity	CACNA2D1 TRPC7 TRPC3 TRPC6 RYR3	1.97e-03	129	137	5	GO:0005262
GeneOntologyMolecularFunction	RNA helicase activity	IFIH1 SUPV3L1 DDX24 DDX39B	2.04e-03	78	137	4	GO:0003724
GeneOntologyMolecularFunction	ATP-dependent activity, acting on RNA	IFIH1 SUPV3L1 DDX24 DDX39B	2.24e-03	80	137	4	GO:0008186
GeneOntologyBiologicalProcess	nuclear migration	SYNE1 CEP120 SYNE2 DOCK7 DYNC1H1	2.86e-06	34	137	5	GO:0007097
GeneOntologyBiologicalProcess	nucleus localization	SYNE1 CEP120 SYNE2 DOCK7 DYNC1H1	1.06e-05	44	137	5	GO:0051647
GeneOntologyBiologicalProcess	replication-born double-strand break repair via sister chromatid exchange	RAD21L1 RECQL5 RAD21	1.57e-05	8	137	3	GO:1990414
GeneOntologyCellularComponent	nuclear protein-containing complex	UTP6 RB1 POLA1 SYNE1 TAF1B ESRRB SLU7 MCM7 XRCC4 MIDEAS ELL3 PRPF18 STAT1 PHF21A PPP1R8 SUDS3 DBF4 SYNE2 DOCK7 AGFG1 CSTF3 DYNLL1 ASCC3 DDX39B	9.76e-06	1377	137	24	GO:0140513
GeneOntologyCellularComponent	supramolecular fiber	KIF18A KRT4 DNAH3 MYO5A SYNE1 SPTAN1 LRRC49 CAPN3 DAXX TTLL8 RYR3 RASSF5 SYNE2 TEKT1 PYGM DYNLL1 RASSF3 MAPRE2 DNAH5 DYNC1H1	8.58e-05	1179	137	20	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	KIF18A KRT4 DNAH3 MYO5A SYNE1 SPTAN1 LRRC49 CAPN3 DAXX TTLL8 RYR3 RASSF5 SYNE2 TEKT1 PYGM DYNLL1 RASSF3 MAPRE2 DNAH5 DYNC1H1	9.40e-05	1187	137	20	GO:0099081
GeneOntologyCellularComponent	microtubule	KIF18A DNAH3 LRRC49 DAXX TTLL8 RASSF5 TEKT1 DYNLL1 RASSF3 MAPRE2 DNAH5 DYNC1H1	2.07e-04	533	137	12	GO:0005874
GeneOntologyCellularComponent	dynein complex	DNAH3 DYNLL1 DNAH5 DYNC1H1	4.33e-04	54	137	4	GO:0030286
GeneOntologyCellularComponent	DNA repair complex	XRCC4 PHF21A ASCC3	4.43e-04	23	137	3	GO:1990391
Domain	Ank_2	TRPC7 TRPC3 TRPC6 ANKRD20A2P ANKRD20A3P ASAP1 ANKRD20A4P ANKRD30A ANKRD36 ANKRD20A1	4.55e-06	215	138	10	PF12796
Domain	Ank	TRPC7 TRPC3 TRPC6 ANKRD20A2P ANKRD20A3P ASAP1 ANKRD20A4P ANKRD30A ANKRD36 ANKRD20A1	7.64e-06	228	138	10	PF00023
Domain	TRP_2	TRPC7 TRPC3 TRPC6	7.77e-06	6	138	3	PF08344
Domain	TRP_dom	TRPC7 TRPC3 TRPC6	7.77e-06	6	138	3	IPR013555
Domain	TRPC_channel	TRPC7 TRPC3 TRPC6	1.35e-05	7	138	3	IPR002153
Domain	-	TRPC7 TRPC3 TRPC6 ANKRD20A2P ANKRD20A3P ASAP1 ANKRD20A4P ANKRD30A ANKRD36 ANKRD20A1	1.59e-05	248	138	10	1.25.40.20
Domain	ANK	TRPC7 TRPC3 TRPC6 ANKRD20A2P ANKRD20A3P ASAP1 ANKRD20A4P ANKRD30A ANKRD36 ANKRD20A1	1.76e-05	251	138	10	SM00248
Domain	ANK_REPEAT	TRPC7 TRPC3 TRPC6 ANKRD20A2P ANKRD20A3P ASAP1 ANKRD20A4P ANKRD30A ANKRD36 ANKRD20A1	1.89e-05	253	138	10	PS50088
Domain	Ankyrin_rpt-contain_dom	TRPC7 TRPC3 TRPC6 ANKRD20A2P ANKRD20A3P ASAP1 ANKRD20A4P ANKRD30A ANKRD36 ANKRD20A1	1.95e-05	254	138	10	IPR020683
Domain	ANK_REP_REGION	TRPC7 TRPC3 TRPC6 ANKRD20A2P ANKRD20A3P ASAP1 ANKRD20A4P ANKRD30A ANKRD36 ANKRD20A1	1.95e-05	254	138	10	PS50297
Domain	Ankyrin_rpt	TRPC7 TRPC3 TRPC6 ANKRD20A2P ANKRD20A3P ASAP1 ANKRD20A4P ANKRD30A ANKRD36 ANKRD20A1	2.55e-05	262	138	10	IPR002110
Domain	HAT	UTP6 ZFC3H1 CSTF3	4.56e-05	10	138	3	SM00386
Domain	HAT	UTP6 ZFC3H1 CSTF3	4.56e-05	10	138	3	IPR003107
Domain	TRP_channel	TRPC7 TRPC3 TRPC6	6.24e-05	11	138	3	IPR004729
Domain	AAA	DNAH3 PSMC4 RNF213 MCM7 ASCC3 DNAH5 DYNC1H1	9.78e-05	144	138	7	SM00382
Domain	AAA+_ATPase	DNAH3 PSMC4 RNF213 MCM7 ASCC3 DNAH5 DYNC1H1	9.78e-05	144	138	7	IPR003593
Domain	I-BAR_dom	ARHGAP42 ARHGAP10 ASAP1	1.07e-04	13	138	3	IPR013606
Domain	Dynein_heavy_chain_D4_dom	DNAH3 DNAH5 DYNC1H1	1.35e-04	14	138	3	IPR024317
Domain	Dynein_HC_stalk	DNAH3 DNAH5 DYNC1H1	1.35e-04	14	138	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH3 DNAH5 DYNC1H1	1.35e-04	14	138	3	IPR013602
Domain	DHC_N2	DNAH3 DNAH5 DYNC1H1	1.35e-04	14	138	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH3 DNAH5 DYNC1H1	1.35e-04	14	138	3	IPR011704
Domain	MT	DNAH3 DNAH5 DYNC1H1	1.35e-04	14	138	3	PF12777
Domain	AAA_8	DNAH3 DNAH5 DYNC1H1	1.35e-04	14	138	3	PF12780
Domain	AAA_5	DNAH3 DNAH5 DYNC1H1	1.35e-04	14	138	3	PF07728
Domain	Helicase_C	IFIH1 SUPV3L1 RECQL5 ASCC3 DDX24 DDX39B	1.43e-04	107	138	6	PF00271
Domain	HELICc	IFIH1 SUPV3L1 RECQL5 ASCC3 DDX24 DDX39B	1.43e-04	107	138	6	SM00490
Domain	Helicase_C	IFIH1 SUPV3L1 RECQL5 ASCC3 DDX24 DDX39B	1.51e-04	108	138	6	IPR001650
Domain	HELICASE_CTER	IFIH1 SUPV3L1 RECQL5 ASCC3 DDX24 DDX39B	1.58e-04	109	138	6	PS51194
Domain	HELICASE_ATP_BIND_1	IFIH1 SUPV3L1 RECQL5 ASCC3 DDX24 DDX39B	1.58e-04	109	138	6	PS51192
Domain	Rad21/Rec8_C_eu	RAD21L1 RAD21	1.62e-04	3	138	2	IPR006909
Domain	Rad21_Rec8_N	RAD21L1 RAD21	1.62e-04	3	138	2	IPR006910
Domain	PHOSPHORYLASE	PYGB PYGM	1.62e-04	3	138	2	PS00102
Domain	Rad21_Rec8_N	RAD21L1 RAD21	1.62e-04	3	138	2	PF04825
Domain	Rad21_Rec8	RAD21L1 RAD21	1.62e-04	3	138	2	PF04824
Domain	Glycg_phsphrylas	PYGB PYGM	1.62e-04	3	138	2	IPR011833
Domain	Glyco_trans_35	PYGB PYGM	1.62e-04	3	138	2	IPR000811
Domain	Rad21/Rec8_C	RAD21L1 RAD21	1.62e-04	3	138	2	IPR023093
Domain	-	RAD21L1 RAD21	1.62e-04	3	138	2	1.10.10.580
Domain	Phosphorylase	PYGB PYGM	1.62e-04	3	138	2	PF00343
Domain	DHC_fam	DNAH3 DNAH5 DYNC1H1	1.68e-04	15	138	3	IPR026983
Domain	Dynein_heavy	DNAH3 DNAH5 DYNC1H1	1.68e-04	15	138	3	PF03028
Domain	Dynein_heavy_dom	DNAH3 DNAH5 DYNC1H1	1.68e-04	15	138	3	IPR004273
Domain	KASH	SYNE1 SYNE2	3.22e-04	4	138	2	IPR012315
Domain	KASH	SYNE1 SYNE2	3.22e-04	4	138	2	PS51049
Domain	KASH	SYNE1 SYNE2	3.22e-04	4	138	2	SM01249
Domain	KASH	SYNE1 SYNE2	3.22e-04	4	138	2	PF10541
Domain	P-loop_NTPase	KIF18A DNAH3 MYO5A PSMC4 RNF213 MCM7 IFIH1 MPP4 SUPV3L1 RECQL5 GNL2 ASCC3 DDX24 DNAH5 DDX39B DYNC1H1	5.33e-04	848	138	16	IPR027417
Domain	Spectrin	SYNE1 SPTAN1 SYNE2	6.27e-04	23	138	3	PF00435
Domain	C-RASSF	RASSF5 RASSF3	7.97e-04	6	138	2	IPR033614
Domain	Nore1-SARAH	RASSF5 RASSF3	7.97e-04	6	138	2	PF16517
Domain	Spectrin_repeat	SYNE1 SPTAN1 SYNE2	1.25e-03	29	138	3	IPR002017
Domain	-	DNAH3 PSMC4 RNF213 MCM7 IFIH1 MPP4 SUPV3L1 RECQL5 GNL2 ASCC3 DDX24 DNAH5 DDX39B DYNC1H1	1.26e-03	746	138	14	3.40.50.300
Domain	DEXDc	IFIH1 RECQL5 ASCC3 DDX24 DDX39B	1.29e-03	109	138	5	SM00487
Domain	Helicase_ATP-bd	IFIH1 RECQL5 ASCC3 DDX24 DDX39B	1.35e-03	110	138	5	IPR014001
Domain	DHC_N1	DNAH5 DYNC1H1	1.47e-03	8	138	2	PF08385
Domain	Dynein_heavy_dom-1	DNAH5 DYNC1H1	1.47e-03	8	138	2	IPR013594
Domain	SPEC	SYNE1 SPTAN1 SYNE2	1.67e-03	32	138	3	SM00150
Domain	Spectrin/alpha-actinin	SYNE1 SPTAN1 SYNE2	1.67e-03	32	138	3	IPR018159
Domain	SARAH	RASSF5 RASSF3	1.89e-03	9	138	2	PS50951
Domain	SARAH_dom	RASSF5 RASSF3	1.89e-03	9	138	2	IPR011524
Domain	DEAD/DEAH_box_helicase_dom	RECQL5 ASCC3 DDX24 DDX39B	2.09e-03	73	138	4	IPR011545
Domain	DEAD	RECQL5 ASCC3 DDX24 DDX39B	2.09e-03	73	138	4	PF00270
Domain	SH3	ARHGAP42 ARHGAP10 SPTAN1 ASAP1 MPP4 SPATA13	5.42e-03	216	138	6	SM00326
Domain	SH3	ARHGAP42 ARHGAP10 SPTAN1 ASAP1 MPP4 SPATA13	5.42e-03	216	138	6	PS50002
Domain	SH3_domain	ARHGAP42 ARHGAP10 SPTAN1 ASAP1 MPP4 SPATA13	5.92e-03	220	138	6	IPR001452
Domain	C345C	SFRP2 NTN3	6.85e-03	17	138	2	SM00643
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	UTP6 MYO5A RB1 POLA1 SPTAN1 TAF1B PSMC4 SLU7 MCM7 MIDEAS STAT1 ASAP1 USP14 MAGED2 SUPV3L1 RECQL5 PIP4K2A XRN1 USP7 PYGB ASCC3 DDX24 MAPRE2 DDX39B DYNC1H1 CCDC93	5.25e-11	1353	143	26	29467282
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	MYO5A POLA1 SPTAN1 TAF1B ESRRB DAXX ZFC3H1 CPED1 CEP350 PIP4K2A XRN1 DOCK7 AGFG1 PPP1R9B ASCC3 DDX24 DDX39B	8.58e-09	724	143	17	36232890
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	UBR2 KIF18A MCMBP MYO5A ARHGAP10 SPTAN1 CEP290 CCDC18 PSMC4 RNF213 ME1 ASAP1 CEP350 PPP1R8 SYNE2 GNL2 USP7 CSTF3 PPP1R9B MAPRE2	1.27e-08	1049	143	20	27880917
Pubmed	Expression of testicular germ cell genes identified by differential display analysis.	ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1	1.89e-08	8	143	4	12634303
Pubmed	Major contribution of the 3/6/7 class of TRPC channels to myocardial ischemia/reperfusion and cellular hypoxia/reoxygenation injuries.	TRPC7 TRPC3 TRPC6	6.81e-08	3	143	3	28526717
Pubmed	Human transcription factor protein interaction networks.	MYO5A RB1 SPTAN1 LRRC49 PSMC4 SLU7 MIDEAS STAT1 PHF21A MAGED2 SUDS3 MYCBP RECQL5 SYNE2 XRN1 GNL2 USP7 DYNLL1 ELK3 DDX24 DYNC1H1 RAD21	9.85e-08	1429	143	22	35140242
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	KIF18A RB1 ARHGAP10 CEP290 PSMC4 MCM7 XRCC4 PHF21A SCYL2 PPP1R8 CEP120 MAGED2 NEK5 RABGAP1L DOCK7 DYNLL1 DDX24 MAPRE2 PRAME DYNC1H1 CCDC93	1.17e-07	1321	143	21	27173435
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	UTP6 SYNE1 RNF213 PIP4K2A XRN1 GNL2 DOCK7 USP7 DYNLL1 ASCC3 DDX24	1.43e-07	332	143	11	25693804
Pubmed	Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1.	KIF18A MCMBP MCM7 PPP1R8 RASSF5 PIP4K2A DOCK7 PPP1R9B DYNLL1 RASSF3	1.94e-07	270	143	10	24366813
Pubmed	Melanopsin Phototransduction Is Repurposed by ipRGC Subtypes to Shape the Function of Distinct Visual Circuits.	TRPC7 TRPC3 TRPC6	2.71e-07	4	143	3	30017393
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	UTP6 MYO5A POLA1 SPTAN1 SYNE2 XRN1 GNL2 DOCK7 USP7 PYGB ASCC3 DDX24 DYNC1H1 RAD21	5.67e-07	653	143	14	22586326
Pubmed	Intrinsic phototransduction persists in melanopsin-expressing ganglion cells lacking diacylglycerol-sensitive TRPC subunits.	TRPC7 TRPC3 TRPC6	6.77e-07	5	143	3	21261756
Pubmed	TRPC channels are necessary mediators of pathologic cardiac hypertrophy.	TRPC7 TRPC3 TRPC6	6.77e-07	5	143	3	20351294
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MCMBP RB1 PSMC4 MCM7 DAXX AASDH RECQL5 PIP4K2A USP7 AGFG1 PYGB DYNLL1 TOP3A	1.04e-06	588	143	13	38580884
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	POLA1 SPTAN1 DAB2 PSMC4 RNF213 DAXX USP7 DDX39B DYNC1H1 RAD21	1.28e-06	332	143	10	32786267
Pubmed	A role for USP7 in DNA replication.	MCMBP MCM7 USP7	1.35e-06	6	143	3	24190967
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CFH MYO5A ACO1 SYNE1 SPTAN1 CEP290 ZFC3H1 STAT1 RYR3 SCYL2 CEP350 SUPV3L1 USP7 OLFM1 DYNLL1 ANKRD36 TARBP1 DYNC1H1 SNX5	1.46e-06	1285	143	19	35914814
Pubmed	Defining the membrane proteome of NK cells.	MYO5A CEP290 GDAP1 PSMC4 SLU7 RNF213 MCM7 CEP350 MAGED2 XRN1 GNL2 PYGB DYNLL1 PARP9 ASCC3 DDX24 DYNC1H1 RAD21	1.58e-06	1168	143	18	19946888
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	UTP6 MCMBP POLA1 SYNE1 SPTAN1 CARS1 PSMC4 MCM7 STAT1 MAGED2 SUPV3L1 GNL2 DOCK7 USP7 CSTF3 DDX24 DNAH5 DDX39B DYNC1H1 RAD21	1.67e-06	1425	143	20	30948266
Pubmed	TRIM11 activates the proteasome and promotes overall protein degradation by regulating USP14.	STAT1 USP14 MAGED2 USP7	2.28e-06	23	143	4	29581427
Pubmed	MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC.	TRPC7 TRPC3 TRPC6	2.35e-06	7	143	3	15757897
Pubmed	TRPC absence induces pro-inflammatory macrophages and gut microbe disorder, sensitizing mice to colitis.	TRPC7 TRPC3 TRPC6	2.35e-06	7	143	3	36592529
Pubmed	Functional role of TRPC proteins in vivo: lessons from TRPC-deficient mouse models.	TRPC7 TRPC3 TRPC6	2.35e-06	7	143	3	15336983
Pubmed	RNA-seq analysis reveals TRPC genes to impact an unexpected number of metabolic and regulatory pathways.	TRPC7 TRPC3 TRPC6	2.35e-06	7	143	3	32350291
Pubmed	TRPC absence induces pro-inflammatory macrophage polarization to promote obesity and exacerbate colorectal cancer.	TRPC7 TRPC3 TRPC6	2.35e-06	7	143	3	38835669
Pubmed	Subunit composition, molecular environment, and activation of native TRPC channels encoded by their interactomes.	TRPC7 TRPC3 TRPC6	2.35e-06	7	143	3	36257322
Pubmed	Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing.	MCMBP FMO3 CAPN3 KHDRBS2 TSGA10 MCM7 RASSF5 CLK2 AGFG1 TEKT1 KCNIP4 ELK3 DDX39B SNX5	2.53e-06	742	143	14	26871637
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	KIF18A PSMC4 ZFC3H1 MIDEAS PPP1R8 SUDS3 RECQL5 CSTF3 PRAME DDX39B TOP3A	3.00e-06	453	143	11	29656893
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SPTAN1 MCM7 MIDEAS STAT1 SCYL2 USP14 XRN1 DOCK7 USP7 DYNLL1 ASCC3 DYNC1H1	3.10e-06	549	143	12	38280479
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	UTP6 KIF18A MYO5A TAF1B SLU7 ZFC3H1 XRCC4 CENPQ MAGED2 XRN1 GNL2 ASCC3 DDX24 RAD21	3.28e-06	759	143	14	35915203
Pubmed	The Chk1-mediated S-phase checkpoint targets initiation factor Cdc45 via a Cdc25A/Cdk2-independent mechanism.	RB1 MCM7 DBF4	3.75e-06	8	143	3	16912045
Pubmed	Metabolism regulates the spontaneous firing of substantia nigra pars reticulata neurons via KATP and nonselective cation channels.	TRPC7 TRPC3 TRPC6	3.75e-06	8	143	3	25471572
Pubmed	Association of immunophilins with mammalian TRPC channels.	TRPC7 TRPC3 TRPC6	3.75e-06	8	143	3	15199065
Pubmed	Subunit composition of mammalian transient receptor potential channels in living cells.	TRPC7 TRPC3 TRPC6	3.75e-06	8	143	3	12032305
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MYO5A SPTAN1 PSMC4 MCM7 XRCC4 ME1 MAGED2 MYCBP DOCK7 USP7 AGFG1 DYNLL1 ASCC3 MAPRE2 DDX39B DYNC1H1 SNX5	5.40e-06	1149	143	17	35446349
Pubmed	Cellular subtype distribution and developmental regulation of TRPC channel members in the mouse dorsal root ganglion.	TRPC7 TRPC3 TRPC6	5.61e-06	9	143	3	17480026
Pubmed	Identification of common binding sites for calmodulin and inositol 1,4,5-trisphosphate receptors on the carboxyl termini of trp channels.	TRPC7 TRPC3 TRPC6	5.61e-06	9	143	3	11290752
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	NLRP11 MYO5A SYNE1 DAXX USP7 DDX24 DNAH5 VPS13B	6.07e-06	234	143	8	36243803
Pubmed	The leak channel NALCN controls tonic firing and glycolytic sensitivity of substantia nigra pars reticulata neurons.	TRPC7 TRPC3 TRPC6	8.00e-06	10	143	3	27177420
Pubmed	Heterogeneous distribution of TRPC proteins in the embryonic cortex.	TRPC7 TRPC3 TRPC6	8.00e-06	10	143	3	18989690
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	MCMBP POLA1 ACO1 SPTAN1 CARS1 PSMC4 MCM7 ME1 STAT1 USP14 MAGED2 MYCBP USP7 AGFG1 PYGB DYNLL1 DDX39B DYNC1H1 SNX5	8.70e-06	1455	143	19	22863883
Pubmed	USP7 Regulates Cytokinesis through FBXO38 and KIF20B.	KIF18A ZFC3H1 SUDS3 USP7 DDX24 TOP3A	8.90e-06	116	143	6	30804394
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	SYNE1 SPTAN1 KHDRBS2 ZFC3H1 OLFM1 DYNC1H1	1.08e-05	120	143	6	31413325
Pubmed	The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer.	MCM7 STAT1 MAGED2 DDX24 RAD21	1.15e-05	71	143	5	29346117
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	SYNE1 SPTAN1 RNF213 ZFC3H1 SYNE2 TEKT1 ANKRD36	1.31e-05	187	143	7	26460568
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	POLA1 SPTAN1 PSMC4 MCM7 SCYL2 MAGED2 USP7 CSTF3 ASCC3 DDX39B DYNC1H1 RAD21	1.40e-05	638	143	12	33239621
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	KIF18A RB1 SPTAN1 CEP290 CCDC18 XRCC4 CEP350 RECQL5 PIP4K2A XRN1 DOCK7 PPP1R9B	1.56e-05	645	143	12	25281560
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	MYO5A SPTAN1 DAB2 RNF213 STAT1 ASCC3 DDX39B DYNC1H1	1.62e-05	268	143	8	33024031
Pubmed	TRPC3 and TRPC6 are essential for normal mechanotransduction in subsets of sensory neurons and cochlear hair cells.	TRPC3 TRPC6	1.68e-05	2	143	2	22724068
Pubmed	Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues.	SYNE1 SYNE2	1.68e-05	2	143	2	11792814
Pubmed	Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration.	SYNE1 SYNE2	1.68e-05	2	143	2	24931616
Pubmed	Modulation of Transient Receptor Potential Channels 3 and 6 Regulates Osteoclast Function with Impact on Trabecular Bone Loss.	TRPC3 TRPC6	1.68e-05	2	143	2	32140760
Pubmed	[Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels].	TRPC3 TRPC6	1.68e-05	2	143	2	20190513
Pubmed	STAT1 is associated with NK cell dysfunction by downregulating NKG2D transcription in chronic HBV-infected patients.	STAT1 KLRK1	1.68e-05	2	143	2	36122437
Pubmed	RNF24, a new TRPC interacting protein, causes the intracellular retention of TRPC.	TRPC6 RNF24	1.68e-05	2	143	2	17850865
Pubmed	Molecular determinants for cardiovascular TRPC6 channel regulation by Ca2+/calmodulin-dependent kinase II.	TRPC7 TRPC6	1.68e-05	2	143	2	23529130
Pubmed	DHA induces Jurkat T-cell arrest in G2/M phase of cell cycle and modulates the plasma membrane expression of TRPC3/6 channels.	TRPC3 TRPC6	1.68e-05	2	143	2	33333171
Pubmed	Ras Regulates Rb via NORE1A.	RB1 RASSF5	1.68e-05	2	143	2	26677227
Pubmed	N-linked protein glycosylation is a major determinant for basal TRPC3 and TRPC6 channel activity.	TRPC3 TRPC6	1.68e-05	2	143	2	12970363
Pubmed	Ubiquitin-independent proteasomal degradation of tumor suppressors by human cytomegalovirus pp71 requires the 19S regulatory particle.	RB1 DAXX	1.68e-05	2	143	2	23408605
Pubmed	PLC-mediated PI(4,5)P2 hydrolysis regulates activation and inactivation of TRPC6/7 channels.	TRPC7 TRPC6	1.68e-05	2	143	2	24470487
Pubmed	Multiple novel nesprin-1 and nesprin-2 variants act as versatile tissue-specific intracellular scaffolds.	SYNE1 SYNE2	1.68e-05	2	143	2	22768332
Pubmed	USP7 and Daxx regulate mitosis progression and taxane sensitivity by affecting stability of Aurora-A kinase.	DAXX USP7	1.68e-05	2	143	2	23348568
Pubmed	Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol.	TRPC3 TRPC6	1.68e-05	2	143	2	9930701
Pubmed	The genetic map around the tail kinks (tk) locus on mouse chromosome 9.	MYO5A ME1	1.68e-05	2	143	2	8268653
Pubmed	Spinophilin acts as a tumor suppressor by regulating Rb phosphorylation.	RB1 PPP1R9B	1.68e-05	2	143	2	21772120
Pubmed	Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy.	TRPC3 TRPC6	1.68e-05	2	143	2	24453217
Pubmed	Myosin Va and Endoplasmic Reticulum Calcium Channel Complex Regulates Membrane Export during Axon Guidance.	MYO5A RYR3	1.68e-05	2	143	2	27134178
Pubmed	Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation.	SYNE1 SYNE2	1.68e-05	2	143	2	17267447
Pubmed	Upregulation and Diverse Roles of TRPC3 and TRPC6 in Synaptic Reorganization of the Mossy Fiber Pathway in Temporal Lobe Epilepsy.	TRPC3 TRPC6	1.68e-05	2	143	2	25213992
Pubmed	Nesprins: tissue-specific expression of epsilon and other short isoforms.	SYNE1 SYNE2	1.68e-05	2	143	2	24718612
Pubmed	Differences in TRPC3 and TRPC6 channels assembly in mesenteric vascular smooth muscle cells in essential hypertension.	TRPC3 TRPC6	1.68e-05	2	143	2	27861908
Pubmed	Targeted ablation of nesprin 1 and nesprin 2 from murine myocardium results in cardiomyopathy, altered nuclear morphology and inhibition of the biomechanical gene response.	SYNE1 SYNE2	1.68e-05	2	143	2	24586179
Pubmed	Structure of the receptor-activated human TRPC6 and TRPC3 ion channels.	TRPC3 TRPC6	1.68e-05	2	143	2	29700422
Pubmed	Transient receptor potential channels function as a coincidence signal detector mediating phosphatidylserine exposure.	TRPC3 TRPC6	1.68e-05	2	143	2	23800468
Pubmed	Phosphorylated retinoblastoma protein stimulates DNA polymerase alpha.	RB1 POLA1	1.68e-05	2	143	2	9395244
Pubmed	TRPC3 participates in angiotensin II type 1 receptor-dependent stress-induced slow increase in intracellular Ca2+ concentration in mouse cardiomyocytes.	TRPC3 TRPC6	1.68e-05	2	143	2	28105583
Pubmed	Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity.	SYNE1 SYNE2	1.68e-05	2	143	2	17761684
Pubmed	Structural mechanism of human TRPC3 and TRPC6 channel regulation by their intracellular calcium-binding sites.	TRPC3 TRPC6	1.68e-05	2	143	2	35051376
Pubmed	Nesprin-1-alpha2 associates with kinesin at myotube outer nuclear membranes, but is restricted to neuromuscular junction nuclei in adult muscle.	SYNE1 SYNE2	1.68e-05	2	143	2	31578382
Pubmed	Diacylglycerol-containing oleic acid induces increases in [Ca(2+)](i) via TRPC3/6 channels in human T-cells.	TRPC3 TRPC6	1.68e-05	2	143	2	22306362
Pubmed	[Regulation of cardiac hypertrophy by the formation of G protein-coupled receptor--TRPC channel protein complex].	TRPC3 TRPC6	1.68e-05	2	143	2	19749484
Pubmed	Cloning and expression of a novel mammalian homolog of Drosophila transient receptor potential (Trp) involved in calcium entry secondary to activation of receptors coupled by the Gq class of G protein.	TRPC3 TRPC6	1.68e-05	2	143	2	9368034
Pubmed	Isoform-selective regulation of glycogen phosphorylase by energy deprivation and phosphorylation in astrocytes.	PYGB PYGM	1.68e-05	2	143	2	25130497
Pubmed	A TRPC3/6 Channel Inhibitor Promotes Arteriogenesis after Hind-Limb Ischemia.	TRPC3 TRPC6	1.68e-05	2	143	2	35805125
Pubmed	Isozymes and genetic control of NADP-malate dehydrogenase in mice.	MYO5A ME1	1.68e-05	2	143	2	4382005
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	UTP6 KRT4 MYO5A SPTAN1 SLU7 MCM7 ZFC3H1 MAGED2 GNL2 DOCK7 USP7 PPP1R9B ASCC3 DDX24 DDX39B DYNC1H1 RAD21	1.73e-05	1257	143	17	36526897
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	KRT4 MCMBP POLA1 TAF1B PSMC4 USP14 MYCBP GNL2 DOCK7 USP7 PPP1R9B DYNLL1 ASCC3 DDX24 TARBP1	1.81e-05	1005	143	15	19615732
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	TRPC7 TRPC3 TRPC6 RYR3	1.81e-05	38	143	4	30786075
Pubmed	Identification and Characterization of USP7 Targets in Cancer Cells.	MAGED2 USP7 DDX24	1.89e-05	13	143	3	30367141
Pubmed	Melanopsin signalling in mammalian iris and retina.	TRPC7 TRPC3 TRPC6	1.89e-05	13	143	3	22051675
Pubmed	Interactions of the human MCM-BP protein with MCM complex components and Dbf4.	MCMBP MCM7 DBF4	1.89e-05	13	143	3	22540012
Pubmed	POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1.	KHDRBS2 PSMC4 SCYL2 USP14 SYNE2 DDX24 DNAH5 DDX39B	2.06e-05	277	143	8	30745168
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	UTP6 CACNA2D1 MYO5A SYNE1 CEP290 MCM7 STAT1 CEP350 SYNE2 GNL2 DOCK7 CSTF3 ASCC3 DDX39B DYNC1H1	2.24e-05	1024	143	15	24711643
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH3 DNAH5 DYNC1H1	2.40e-05	14	143	3	9373155
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	POLA1 CARS1 DAB2 MIDEAS ASAP1 SCYL2 USP7 CSTF3 MAPRE2 DDX39B	2.76e-05	472	143	10	38943005
Pubmed	The C-terminal cytoplasmic tail of hedgehog receptor Patched1 is a platform for E3 ubiquitin ligase complexes.	KHDRBS2 PSMC4 FIG4 PIP4K2A DYNC1H1	2.92e-05	86	143	5	26885983
Pubmed	FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells.	MCMBP ACO1 PSMC4 PPP1R8 CSTF3 ASCC3 DDX24	2.94e-05	212	143	7	33462405
Pubmed	PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation.	MCM7 MAGED2 SUDS3 USP7 ASCC3 DDX24 RAD21	3.41e-05	217	143	7	31685992
Pubmed	A human MAP kinase interactome.	SYNE1 SPTAN1 CEP290 DAB2 DAXX MIDEAS STAT1 ASAP1 CEP350 AGFG1	3.53e-05	486	143	10	20936779
Interaction	ANKRD20A4P interactions	ANKRD20A2P ANKRD20A4P DYNLL1 ANKRD20A1	3.41e-08	6	141	4	int:ANKRD20A4P
Interaction	ANKRD20A2P interactions	ANKRD20A2P ANKRD20A4P DYNLL1 ANKRD20A1	7.91e-08	7	141	4	int:ANKRD20A2P
Interaction	MIB1 interactions	LRRC49 CEP290 CCDC18 DAB2 MCM7 ZFC3H1 SCYL2 XRN1 AGFG1 DYNLL1 ASCC3 TOP3A SNX5	1.61e-07	295	141	13	int:MIB1
Interaction	MECOM interactions	PSMC4 MCM7 PHF21A MAGED2 MYCBP RABGAP1L GNL2 USP7 PYGM PPP1R9B ELK3 DDX24 DYNC1H1	1.44e-06	358	141	13	int:MECOM
Interaction	TRPC7 interactions	TRPC7 TRPC3 TRPC6	6.60e-06	6	141	3	int:TRPC7
Interaction	BRCA2 interactions	CFH DAXX PHF21A FIG4 CLK2 DBF4 RECQL5 PYGM POLN DYNC1H1 TOP3A RAD21	1.69e-05	384	141	12	int:BRCA2
Interaction	PPP1CB interactions	KIF18A MCMBP SFRP2 MYO5A RB1 SPTAN1 DAB2 PSMC4 RNF213 PPP1R8 PPP1R9B DDX24 DYNC1H1	2.63e-05	469	141	13	int:PPP1CB
Interaction	IFI16 interactions	UTP6 SYNE1 SPTAN1 PSMC4 RNF213 MCM7 MAGED2 RABGAP1L PIP4K2A XRN1 GNL2 DOCK7 USP7 DYNLL1 ASCC3 DDX24	4.09e-05	714	141	16	int:IFI16
Interaction	ANKRD20A1 interactions	ANKRD20A2P ANKRD20A4P ANKRD20A1	5.31e-05	11	141	3	int:ANKRD20A1
Interaction	BRCA1 interactions	UBR2 KIF18A RB1 ACO1 SPTAN1 TAF1B CARS1 PSMC4 STAT1 CEP350 CLK2 DBF4 RECQL5 USP7 PPP1R9B POLN DDX24 PRAME DDX39B DYNC1H1 TOP3A RAD21	5.60e-05	1249	141	22	int:BRCA1
Interaction	H3C1 interactions	ARHGAP10 POLA1 SYNE1 SPTAN1 TAF1B CEP290 MCM7 DAXX MIDEAS RECQL5 GNL2 USP7 CSTF3 DDX24 MAPRE2 TARBP1 DYNC1H1 RAD21	5.90e-05	901	141	18	int:H3C1
Interaction	SIRT7 interactions	UTP6 MYO5A RB1 POLA1 SPTAN1 MCM7 SYNE2 XRN1 GNL2 DOCK7 USP7 PYGB ASCC3 DDX24 DYNC1H1 RAD21	6.65e-05	744	141	16	int:SIRT7
Interaction	ITSN1 interactions	SYNE1 SPTAN1 DAB2 ZFC3H1 ASAP1 AGFG1 ANKRD36 DYNC1H1 SNX5	8.91e-05	259	141	9	int:ITSN1
Interaction	DBF4 interactions	MCMBP MCM7 DAXX DBF4	9.05e-05	34	141	4	int:DBF4
Interaction	DYNLL2 interactions	MYO5A ANKRD20A2P XRCC4 ANKRD20A4P SUDS3 MYCBP DYNLL1 DYNC1H1 ANKRD20A1	1.00e-04	263	141	9	int:DYNLL2
Interaction	KDM1A interactions	RB1 ESRRB LRRC49 SLU7 MCM7 PHF21A CENPQ CEP350 MYCBP RABGAP1L XRN1 DOCK7 USP7 DYNLL1 RASSF3 ASCC3 PRAME CCDC93	1.02e-04	941	141	18	int:KDM1A
Interaction	ACTC1 interactions	POLA1 SYNE1 SPTAN1 PSMC4 ATP8B2 STAT1 SCYL2 USP14 SYNE2 DOCK7 USP7 PPP1R9B DYNLL1 DDX39B DYNC1H1	1.08e-04	694	141	15	int:ACTC1
Interaction	USP7 interactions	NLRP11 CACNA2D1 MCMBP MYO5A RB1 POLA1 SYNE1 NTN3 SPTAN1 KHDRBS2 DAXX XRCC4 USP14 MAGED2 CLK2 TTC29 DOCK7 USP7 DDX24 DNAH5 DYNC1H1 VPS13B	1.16e-04	1313	141	22	int:USP7
GeneFamily	X-linked mental retardation\|RNA helicases	IFIH1 SUPV3L1 ASCC3	2.62e-05	11	100	3	1168
GeneFamily	Glycogen phosphorylases	PYGB PYGM	9.05e-05	3	100	2	437
GeneFamily	Spectrin repeat containing nuclear envelope family	SYNE1 SYNE2	1.80e-04	4	100	2	1252
GeneFamily	Ankyrin repeat domain containing	ANKRD20A2P ANKRD20A3P ASAP1 ANKRD20A4P ANKRD30A ANKRD36 ANKRD20A1	3.93e-04	242	100	7	403
GeneFamily	Transient receptor potential cation channels	TRPC7 TRPC3 TRPC6	4.86e-04	28	100	3	249
GeneFamily	Ras association domain family	RASSF5 RASSF3	1.32e-03	10	100	2	1198
GeneFamily	Dyneins, cytoplasmic	DYNLL1 DYNC1H1	2.27e-03	13	100	2	538
GeneFamily	Dyneins, axonemal	DNAH3 DNAH5	3.90e-03	17	100	2	536
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	UBR2 MCMBP MYO5A SYNE1 SPTAN1 RNF213 DAXX ZFC3H1 ATP8B2 STAT1 ASAP1 CEP350 RASSF5 ERAP2 RABGAP1L PIP4K2A XRN1 AGFG1 PARP9 ASCC3 DDX24 MAPRE2 DYNC1H1 VPS13B SPATA13 RAD21	1.33e-07	1492	143	26	M40023
Coexpression	DODD_NASOPHARYNGEAL_CARCINOMA_UP	UTP6 KIF18A CACNA2D1 MCMBP POLA1 CCDC18 RNF213 MCM7 XRCC4 STAT1 ASAP1 CENPQ SCYL2 IFIH1 USP14 DBF4 SUPV3L1 DOCK7 CSTF3 OLFM1 ASCC3 TARBP1 SNX5 RAD21	6.35e-07	1407	143	24	M14427
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	KIF18A MYO5A ARHGAP10 TAF1B CEP290 SLU7 XRCC4 STAT1 CENPQ CEP350 IFIH1 DBF4 RABGAP1L SYNE2 OLFM1 RAD21	6.37e-07	656	143	16	M18979
Coexpression	GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN	UTP6 CARS1 STAT1 SCYL2 IFIH1 ERAP2 USP7 ASCC3 RNF24	1.62e-06	200	143	9	M3411
Coexpression	GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN	STAT1 PHF21A ASAP1 SGK3 TG IFIH1 RASSF5 AGFG1 SPATA13	1.62e-06	200	143	9	M7205
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	UBR2 TAF1B CEP290 CARS1 DAB2 XRCC4 ELL3 RYR3 SCYL2 CEP350 ERAP2 DBF4 MYCBP RABGAP1L SYNE2 PIP4K2A PYGB ASCC3 DYNC1H1 TOP3A CCDC93	2.83e-06	1215	143	21	M41122
Coexpression	GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP	DAB2 SLU7 AASDH STPG4 RASSF5 ANKRD36 RNF24 MAPRE2	1.14e-05	193	143	8	M6730
Coexpression	GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	MCMBP CAPN3 ELL3 CENPQ DBF4 AGFG1 DYNLL1 RAD21	1.42e-05	199	143	8	M8113
Coexpression	GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP	PRPF18 PHF21A ASAP1 TG CEP120 PIP4K2A PARP9 SPATA13	1.42e-05	199	143	8	M6934
Coexpression	GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN	CARS1 ELL3 CENPQ SGK3 IFIH1 MPP4 SUPV3L1 MYCBP	1.47e-05	200	143	8	M4845
Coexpression	GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP	MPEG1 RNF213 DAXX MIDEAS STAT1 IFIH1 PARP9 SPATA13	1.47e-05	200	143	8	M8559
Coexpression	GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	MPEG1 RNF213 DAXX CCDC160 STAT1 KLRK1 IFIH1 PARP9	1.47e-05	200	143	8	M7320
Coexpression	GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN	DAXX STAT1 SGK3 IFIH1 SYNE2 AGFG1 PARP9 DDX24	1.47e-05	200	143	8	M9020
Coexpression	GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP	DAXX STAT1 KLRK1 IFIH1 HAVCR1 SYNE2 PARP9 DDX24	1.47e-05	200	143	8	M9030
Coexpression	GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP	UBR2 DAXX STAT1 IFIH1 TMTC4 PARP9 PNPLA7 DDX24	1.47e-05	200	143	8	M9051
Coexpression	FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON	SYNE1 KHDRBS2 DAB2 RNF213 RYR3 ANKRD36 TARBP1	3.66e-05	166	143	7	M39026
Coexpression	SANA_RESPONSE_TO_IFNG_UP	CFH RNF213 STAT1 IFIH1 PARP9	6.10e-05	76	143	5	M4551
Coexpression	LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES	CACNA2D1 SYNE1 ASAP1 RABGAP1L PIP4K2A ADGRF5	1.09e-04	137	143	6	M39241
Coexpression	GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP	CFH KIF18A STAT1 IFIH1 RABGAP1L SYNE2 CSTF3	1.14e-04	199	143	7	M9568
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL	KIF18A MCMBP POLA1 TAF1B CCDC18 DAB2 MCM7 CENPQ KLRK1 USP14 DBF4 SYNE2 ANKRD36	1.15e-04	694	143	13	M45767
Coexpression	GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP	MYO1H NTN3 CEP290 ELL3 HAVCR1 DOCK7 OLFM1	1.18e-04	200	143	7	M9316
Coexpression	GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN	ARHGAP10 RNF213 DAXX STAT1 USP7 ASCC3 DDX24	1.18e-04	200	143	7	M9341
Coexpression	GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN	UTP6 UBR2 STAT1 IFIH1 ERAP2 USP7 ASCC3	1.18e-04	200	143	7	M3414
Coexpression	GSE27786_LIN_NEG_VS_NKCELL_DN	MYO5A STAT1 ITPK1 AGFG1 PARP9 DYNC1H1 VPS13B	1.18e-04	200	143	7	M4784
Coexpression	GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP	MPEG1 RNF213 DAXX ELL3 STAT1 IFIH1 PARP9	1.18e-04	200	143	7	M8554
Coexpression	GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP	UTP6 MPEG1 RNF213 DAXX STAT1 IFIH1 PARP9	1.18e-04	200	143	7	M8564
Coexpression	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	MPEG1 RNF213 DAXX STAT1 KLRK1 IFIH1 PARP9	1.18e-04	200	143	7	M7322
Coexpression	GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP	CCDC18 RNF213 DAXX STAT1 SGK3 IFIH1 PARP9	1.18e-04	200	143	7	M7324
Coexpression	GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN	UTP6 ARHGAP10 MYO1H MPEG1 KLRK1 CSTF3 PARP9	1.18e-04	200	143	7	M3975
Coexpression	GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN	FMO3 SYNE1 KLRK1 PNPLA7 MAPRE2 DYNC1H1 SNX5	1.18e-04	200	143	7	M5043
Coexpression	GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP	RNF213 DAXX KLRK1 IFIH1 HAVCR1 AGFG1 ASCC3	1.18e-04	200	143	7	M6256
Coexpression	GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN	MYO5A SGK3 SUPV3L1 CSTF3 PNPLA7 ASCC3 CCDC93	1.18e-04	200	143	7	M6993
Coexpression	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	ITPK1 SGK3 OLFM1	1.22e-04	18	143	3	M8583
Coexpression	AIZARANI_LIVER_C17_HEPATOCYTES_3	CFH CYP8B1 ADH4 SERPIND1 KNG1	2.45e-04	102	143	5	M39119
Coexpression	GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP	RB1 ARHGAP10 ZFC3H1 CEP350 RABGAP1L XRN1	2.53e-04	160	143	6	M339
Coexpression	GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN	RNF213 STAT1 ITPK1 IFIH1 PYGB PPP1R9B	2.53e-04	160	143	6	M8664
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	UBR2 RB1 XRCC4 PHF21A CEP350 DBF4 RABGAP1L SYNE2 PIP4K2A USP7 AGFG1 ASCC3 VPS13B CCDC93	2.56e-04	856	143	14	M4500
Coexpression	FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2	ARHGAP42 CFH ARHGAP10 TRPC6 MAGED2 SYNE2 RNF24 CDH6	2.68e-04	303	143	8	M39040
Coexpression	PATIL_LIVER_CANCER	GDAP1 RNF213 PHF21A ASAP1 CENPQ CLK2 PYGB RASSF3 TARBP1 DYNC1H1 CCDC93 RAD21	2.78e-04	660	143	12	M1195
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	UBR2 RNF213 ZFC3H1 STAT1 CEP350 IFIH1 SYNE2 XRN1 PARP9 DDX24 DYNC1H1	5.26e-11	200	143	11	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Calu_3-infected-SARSCoV2\|infected / Cell line, Condition and Strain	CFH RNF213 STAT1 IFIH1 ERAP2 RABGAP1L SYNE2 XRN1 PARP9 KNG1	6.57e-10	191	143	10	2da876d26f37a00dbdf1ee79d724306e8b20f304
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	RNF213 STAT1 CEP350 IFIH1 ERAP2 RABGAP1L SYNE2 XRN1 PARP9	8.35e-09	183	143	9	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	ARHGAP42 DNAH3 SYNE1 NEK5 TTC29 SYNE2 TEKT1 ADGRF5 DNAH5	1.45e-08	195	143	9	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	ARHGAP42 DNAH3 SYNE1 NEK5 TTC29 SYNE2 TEKT1 ADGRF5 DNAH5	1.45e-08	195	143	9	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ACO1 TRPC6 RNF213 STAT1 IFIH1 XRN1 PARP9 TARBP1	1.01e-07	175	143	8	97616bb5c127284aa9e67bc336dfcf29e137164b
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	ARHGAP42 DNAH3 SYNE1 TTC29 SYNE2 TEKT1 ADGRF5 DNAH5	2.42e-07	196	143	8	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	ARHGAP42 DNAH3 SYNE1 TTC29 SYNE2 TEKT1 ADGRF5 DNAH5	2.42e-07	196	143	8	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE1 RNF213 ZFC3H1 SYNE2 XRN1 ANKRD36 DDX24 DDX39B	2.51e-07	197	143	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	systemic_lupus_erythematosus-treated\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SYNE1 RNF213 STAT1 SYNE2 PIP4K2A XRN1 PARP9 DDX39B	2.61e-07	198	143	8	8165ff735095c52994fb5057d89be93cc378b7da
ToppCell	CV\|World / Virus stimulation, Condition and Cluster	SYNE1 SPTAN1 RNF213 STAT1 ERAP2 SYNE2 DYNLL1 PARP9	2.61e-07	198	143	8	6a28193af35abec5c029129930c2ca6febaafde2
ToppCell	CD8+_Memory_T_cell-CV\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	SYNE1 SPTAN1 RNF213 STAT1 ERAP2 SYNE2 DYNLL1 PARP9	2.61e-07	198	143	8	3d1749f5106f0912f4a74615863853949f52c73d
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	UBR2 SYNE1 RNF213 ZFC3H1 SYNE2 ANKRD36 DDX24 VPS13B	2.71e-07	199	143	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	mild-MAIT\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CFH SYNE1 RNF213 ME1 SYNE2 PIP4K2A ELK3 DDX24	2.71e-07	199	143	8	cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84
ToppCell	COVID-19_Moderate\|World / disease group, cell group and cell class	SYNE1 RNF213 STAT1 IFIH1 SYNE2 XRN1 PARP9 DDX24	2.71e-07	199	143	8	952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SPTAN1 RNF213 STAT1 SYNE2 XRN1 ADGRF5 ELK3 DYNC1H1	2.82e-07	200	143	8	89821a264e872ed53e08e9d3609d5cc5c314503e
ToppCell	critical-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KIF18A MCMBP RB1 CCDC18 MCM7 CEP350 CEP120 DBF4	2.82e-07	200	143	8	f39db4250ce220a3eb58edee3f7fc3671701d46f
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	RNF213 STAT1 SYNE2 XRN1 USP7 DDX24 DYNC1H1 RAD21	2.82e-07	200	143	8	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	MS-CD4-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	RNF213 ANKRD20A8P STAT1 TG IFIH1 SYNE2 PARP9	6.22e-07	152	143	7	b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee
ToppCell	Control-Fibroblasts-Pericytes\|Control / group, cell type (main and fine annotations)	ARHGAP42 CACNA2D1 ARHGAP10 TRPC3 TRPC6 ASAP1 CDH6	1.37e-06	171	143	7	080003f698f867935c2bfc55d241d3650f45a0ab
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFH MYO5A DAB2 MPEG1 RNF213 PIP4K2A SNX5	1.43e-06	172	143	7	c96bd3407911df3e3e6d7a3dba786b11814b9598
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF18A SFRP2 TSGA10 TTLL8 TEKT1 PYGB DNAH5	2.31e-06	185	143	7	05bc89a566b0db90ae06506e067190a4739a0974
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	RNF213 STAT1 IFIH1 ERAP2 SYNE2 XRN1 PARP9	2.57e-06	188	143	7	6f8946d4710f6e32c937213f99b790b098b8819c
ToppCell	Epithelial-Epithelial-D_(Ciliated)\|Epithelial / shred on cell class and cell subclass (v4)	DNAH3 SYNE1 CEP290 NEK5 MYCBP TEKT1 DNAH5	2.57e-06	188	143	7	8f30535a32968a81a304315a49c0d90a77d36948
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 CACNA2D1 SYNE1 TRPC3 TRPC6 CPED1 CDH6	2.67e-06	189	143	7	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SYNE1 RNF213 KLRK1 SYNE2 XRN1 ANKRD36 MAPRE2	2.76e-06	190	143	7	d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP42 ARHGAP10 TRPC3 TRPC6 CPED1 ADGRF5 CDH6	2.76e-06	190	143	7	5681c211baeed4af82a2bbc13420f6a7b487581c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 CACNA2D1 SYNE1 TRPC3 TRPC6 CPED1 CDH6	2.86e-06	191	143	7	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	COVID-19_Severe-CD8+_T_activated\|World / disease group, cell group and cell class	CFH ARHGAP10 SYNE1 RNF213 SYNE2 PARP9 DDX24	3.06e-06	193	143	7	ddc1db516568e03be8e82b2ca770c67756418185
ToppCell	IPF-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH3 SYNE1 TSGA10 NEK5 TTC29 TEKT1 DNAH5	3.06e-06	193	143	7	ad58f5080e0ba65c845056ea6b79037b636e9c64
ToppCell	IPF-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	ARHGAP42 TRPC3 TRPC6 ASAP1 SYNE2 ADGRF5 CDH6	3.17e-06	194	143	7	3892b188f424ffb80f3c75a1b6709a21c1e1601d
ToppCell	IPF-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	ARHGAP42 DNAH3 NEK5 TTC29 SYNE2 TEKT1 DNAH5	3.28e-06	195	143	7	21dbdc803c6947024dc2416e9e21c2ef0af9bc31
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid-Microglia\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	MPEG1 RNF213 XRCC4 CPED1 CENPQ RASSF5 ELK3	3.39e-06	196	143	7	89a0ccd0684777927d99d5fc5b7c498f3f124250
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	MPEG1 RNF213 XRCC4 CPED1 CENPQ RASSF5 ELK3	3.39e-06	196	143	7	91a8c4798572d6c1f03cef5e8e5464ed0046c7cf
ToppCell	Mild-CD8+_T_activated\|World / Disease group and Cell class	STAT1 KLRK1 IFIH1 ERAP2 XRN1 PARP9 TARBP1	3.39e-06	196	143	7	79632190e44fcef9d7c11d9b9e37f2ebf0e6e255
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 SYNE1 LRRC49 NEK5 TTC29 TEKT1 DNAH5	3.51e-06	197	143	7	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 SYNE1 CEP290 TSGA10 NEK5 SYNE2 DNAH5	3.51e-06	197	143	7	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	CEP290 CCDC18 ZFC3H1 CEP350 GNL2 ANKRD36 KNG1	3.51e-06	197	143	7	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	control-CD163+_Monocytes_(Sample_ID1_d7)\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MPEG1 RNF213 STAT1 IFIH1 FCN1 RABGAP1L PARP9	3.75e-06	199	143	7	933201d32eda12a89660bdbae9114a95cc428a38
ToppCell	VE-CD4-antiviral_CD4\|VE / Condition, Cell_class and T cell subcluster	RNF213 STAT1 IFIH1 SYNE2 XRN1 PARP9 TARBP1	3.75e-06	199	143	7	056a0538ca5e825ae6195b4c76c208708a014533
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	SYNE1 SPTAN1 RNF213 ATP8B2 SYNE2 PIP4K2A ANKRD36	3.75e-06	199	143	7	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	PBMC-Severe-cDC_9\|Severe / Compartment, Disease Groups and Clusters	UTP6 RNF213 STAT1 IFIH1 RABGAP1L DYNLL1 PARP9	3.87e-06	200	143	7	ea3b22126d9dfd158bb3c3e1323b30514d721ded
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE1 RNF213 SYNE2 PIP4K2A XRN1 PARP9 DDX24	3.87e-06	200	143	7	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	ARHGAP42 ARHGAP10 TRPC3 TRPC6 PCDHA10 SYNE2 CDH6	3.87e-06	200	143	7	0c648941447c738caf62f2d71e296d6cca492c8b
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Ciliated\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	DNAH3 SYNE1 TSGA10 NEK5 TTC29 TEKT1 DNAH5	3.87e-06	200	143	7	6a2ccc71a0cbe04a542c379b28b5006de53981c3
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARHGAP42 ARHGAP10 TRPC3 TRPC6 PCDHA10 SYNE2 CDH6	3.87e-06	200	143	7	522a51a284d2992d519c4669e1a48c8ebcc08c80
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE1 RNF213 KLRK1 SYNE2 PIP4K2A XRN1 DDX24	3.87e-06	200	143	7	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	SPTAN1 RNF213 ATP8B2 STAT1 IFIH1 SYNE2 PARP9	3.87e-06	200	143	7	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	ARHGAP42 ARHGAP10 SYNE1 TRPC3 TRPC6 CPED1 CDH6	3.87e-06	200	143	7	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ARHGAP42 ARHGAP10 TRPC3 TRPC6 PCDHA10 SYNE2 CDH6	3.87e-06	200	143	7	94f1fa61aa82eb9f411b2b1cb759476939ab5db7
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	ARHGAP42 ARHGAP10 SYNE1 TRPC3 TRPC6 CPED1 CDH6	3.87e-06	200	143	7	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2\|Control_saline / Treatment groups by lineage, cell group, cell type	ARHGAP42 SFRP2 COL6A6 TRPC3 TRPC6 CPED1 CDH6	3.87e-06	200	143	7	bc8949eb34482aca166c4602ff6ab876cb4c2c3c
ToppCell	AT2_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	ANKRD20A2P ANKRD20A3P LRRC70 RYR3 ANKRD20A4P SERPIND1	4.18e-06	131	143	6	ff4e618bd944f852bbd34438f740187aca82460f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RYR3 HAVCR1 SYNE2 KCNIP4 DNAH5 CDH6	1.51e-05	164	143	6	1cb5fbd7050650047ad6f2ca792118e98d58d22b
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10\|TCGA-Brain / Sample_Type by Project: Shred V9	CYP8B1 RYR3 NEK5 TTC29 TEKT1 DNAH5	1.92e-05	171	143	6	74be8d3bf6b99e2d734635a8b1a7c41e8c596959
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH MYO5A DAB2 MPEG1 ZFC3H1 RASSF3	2.05e-05	173	143	6	869da6a65d1b9b7529c666ec44e3c8ddec2ea408
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH MYO5A DAB2 MPEG1 ZFC3H1 RASSF3	2.05e-05	173	143	6	0672bd8a4a9d18af343d01f09253fb3388896c10
ToppCell	facs-Brain_Myeloid-Cerebellum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFH MYO5A DAB2 MPEG1 ZFC3H1 RASSF3	2.05e-05	173	143	6	870e091ec30be01a900e1cb8b9ef1880e3b7b50d
ToppCell	COVID-19-kidney-PCT-S3-2\|kidney / Disease (COVID-19 only), tissue and cell type	CFH FMO3 CYP8B1 ANKRD20A2P ADH4 KNG1	2.11e-05	174	143	6	5aa2fb631505600f37d2b87b02def7be139dc262
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFH MYO5A DAB2 MPEG1 PNPLA7 SNX5	2.26e-05	176	143	6	adb679e69c0c17f0caee4c141bac55d03c963012
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CFH MYO5A DAB2 MPEG1 PNPLA7 SNX5	2.33e-05	177	143	6	ab92ffc9624850a50c88e6b8f3a517ff2251ff15
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP42 ARHGAP10 TRPC6 ASAP1 ADGRF5 CDH6	2.33e-05	177	143	6	a8625d14682183cf77cb51eaf11bc15a3528f586
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP42 ARHGAP10 TRPC6 ASAP1 ADGRF5 CDH6	2.33e-05	177	143	6	3645e2f4a48283f290f85c49c3e79e3f58ac9aa6
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARHGAP42 CACNA2D1 COL6A6 TRPC3 TRPC6 CDH6	2.40e-05	178	143	6	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 STAT1 IFIH1 SYNE2 XRN1 ASCC3	2.40e-05	178	143	6	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	Ciliated_cells-A-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH3 FMO3 CCDC160 NEK5 TTC29 TEKT1	2.40e-05	178	143	6	255473ee6df8a13079fb3bb61038162a40cb4c2c
ToppCell	T_cells-ISG-high_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	RNF213 STAT1 IFIH1 ERAP2 XRN1 PARP9	2.48e-05	179	143	6	af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP42 CACNA2D1 ARHGAP10 TRPC3 TRPC6 CDH6	2.48e-05	179	143	6	dc6cd46fa652b296ddbc41855f6377946d0a4cdc
ToppCell	droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF18A DAB2 ME1 CENPQ DBF4 KCNIP4	2.56e-05	180	143	6	43fd5c498a87bb078d101298b472656f3294686a
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ARHGAP42 CACNA2D1 ARHGAP10 TRPC3 TRPC6 CDH6	2.64e-05	181	143	6	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	368C-Lymphocytic-CD4_T-cell-Treg_cell_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	RNF213 CEP120 SUPV3L1 SYNE2 CUZD1 CCDC93	2.64e-05	181	143	6	b193f3606554adc55c5906219d114288bb1f978a
ToppCell	18-Airway-Epithelial-Multiciliated_precursor\|Airway / Age, Tissue, Lineage and Cell class	MYO1H CCDC18 TSGA10 ANKRD20A4P TEKT1 ANKRD20A1	2.81e-05	183	143	6	a75cda2131755931117c387f2e0ae3394efa8e80
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 SFRP2 TRPC3 TRPC6 CPED1 CDH6	2.81e-05	183	143	6	8a799807fbf24456a9811e0c64068187940a2f71
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 COL6A6 TRPC3 TRPC6 CPED1 CDH6	2.90e-05	184	143	6	689a8af81a79a4bb3123cfa01958c953eab5de98
ToppCell	Control-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	RAD21L1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1	2.90e-05	184	143	6	c6affa0b12510363258f65e46bf2d47bf4a8e75f
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	ARHGAP42 ARHGAP10 TRPC3 TRPC6 ADGRF5 CDH6	2.98e-05	185	143	6	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	LA-07._Pericyte\|LA / Chamber and Cluster_Paper	ARHGAP42 ARHGAP10 TRPC6 ASAP1 ADGRF5 CDH6	2.98e-05	185	143	6	ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP42 ARHGAP10 TRPC3 TRPC6 PCDHA10 CDH6	3.08e-05	186	143	6	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA2D1 ARHGAP10 SYNE1 TRPC6 CPED1 CDH6	3.08e-05	186	143	6	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	Control-Myeloid-cDC1\|Control / Disease state, Lineage and Cell class	RAD21L1 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P ANKRD20A1	3.08e-05	186	143	6	b05c394aa3573ba855abc3066739ca193883b0c3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP42 ARHGAP10 TRPC6 CPED1 ADGRF5 CDH6	3.17e-05	187	143	6	ec4b694487cc446999c7b27b119950a4f252c4b3
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ARHGAP42 CACNA2D1 SFRP2 TRPC3 TRPC6 CPED1	3.17e-05	187	143	6	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	critical-Myeloid-Monocyte-derived_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ARHGAP10 RNF213 CPED1 IFIH1 RABGAP1L XRN1	3.17e-05	187	143	6	72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP42 ARHGAP10 TRPC6 CPED1 ADGRF5 CDH6	3.17e-05	187	143	6	530e4e6d91b5c0d9aa4543caa2b734a1674c5788
ToppCell	3'_v3-blood-Lymphocytic_T_CD8\|blood / Manually curated celltypes from each tissue	SYNE1 CARS1 RNF213 KLRK1 SYNE2 PIP4K2A	3.46e-05	190	143	6	5dca8654964c41580fa3b094579fe7cb296d406f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA2D1 FMO3 ARHGAP10 SYNE1 CPED1 ASAP1	3.46e-05	190	143	6	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH3 SYNE1 NEK5 TTC29 TEKT1 DNAH5	3.46e-05	190	143	6	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	SYNE1 KHDRBS2 ANKRD20A2P ANKRD20A4P ADGRF5 SPATA13	3.46e-05	190	143	6	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	DNAH3 SYNE1 NEK5 TTC29 TEKT1 DNAH5	3.46e-05	190	143	6	833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CACNA2D1 FMO3 ARHGAP10 SYNE1 CPED1 ASAP1	3.46e-05	190	143	6	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGAP10 TRPC3 KHDRBS2 OLFM1 KCNIP4 RASSF3	3.46e-05	190	143	6	1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	CFH SYNE1 RNF213 KLRK1 SYNE2 PIP4K2A	3.46e-05	190	143	6	66d29f53f129fc18771f6214316a913eeaccd55e
ToppCell	3'_v3-blood-Lymphocytic_T_CD8-Tem/emra_CD8\|blood / Manually curated celltypes from each tissue	CFH SYNE1 RNF213 KLRK1 SYNE2 PIP4K2A	3.46e-05	190	143	6	5624f711b34132081f93fa70702316962e3e3c64
ToppCell	PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 CEP290 NEK5 TTC29 TEKT1 DNAH5	3.57e-05	191	143	6	bda8faf92495c8b362850c0aff4fc6fbdd9c563b
ToppCell	PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 CEP290 NEK5 TTC29 TEKT1 DNAH5	3.57e-05	191	143	6	6880fb348bb0915db9a5da4f3566ca9ff93ed258
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ARHGAP42 SYNE1 TRPC3 TRPC6 CPED1 CDH6	3.57e-05	191	143	6	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP42 ARHGAP10 TRPC3 TRPC6 PCDHA10 CDH6	3.57e-05	191	143	6	1626b23a57429f835fddc052e3c57f63a4e5b8bb
ToppCell	PND07-Epithelial-Epithelial_Airway\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KRT4 DNAH3 NEK5 TTC29 TEKT1 DNAH5	3.57e-05	191	143	6	b55500eb416f4f339031acad16b2737e5b891d8e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP42 ARHGAP10 TRPC3 TRPC6 PCDHA10 CDH6	3.57e-05	191	143	6	716dfa7fccbd62b5f574792e68a26dc6c45511dc
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ARHGAP42 ARHGAP10 TRPC6 CPED1 ASAP1 ADGRF5	3.57e-05	191	143	6	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
Drug	NSC-167055	POLA1 SYNE1 POLN	2.35e-06	5	142	3	CID005383385
Drug	maltohexaose	TRPC7 CAPN3 OLFM1 PYGB PYGM	4.27e-06	39	142	5	CID000439606
Drug	CV-araU	POLA1 PYGB PYGM	4.69e-06	6	142	3	CID006441877
Drug	DNPP	KRT4 PYGB PYGM	4.69e-06	6	142	3	CID000067056
Drug	AR-L57	CACNA2D1 PYGB PYGM	4.69e-06	6	142	3	CID000156890
Drug	heptenitol	CAPN3 PYGB PYGM	8.16e-06	7	142	3	CID000188267
Drug	AC1NUVX5	POLA1 PYGB PYGM	1.30e-05	8	142	3	CID005461894
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; HL60; HT_HG-U133A	SYNE1 CEP290 GDAP1 XRCC4 MAGED2 RECQL5 OLFM1 VPS13B	3.28e-05	196	142	8	3069_DN
Drug	borate	TRPC3 TRPC6 PSMC4 SLU7 PHF21A RYR3	3.48e-05	98	142	6	CID000007628
Drug	glucosyl fluoride	CAPN3 PYGB PYGM	3.78e-05	11	142	3	CID000150967
Drug	steffimycin B	POLA1 POLN	3.86e-05	2	142	2	CID000099762
Drug	FSBdA	POLA1 POLN	3.86e-05	2	142	2	CID000195479
Drug	AC1L4423	POLA1 POLN	3.86e-05	2	142	2	CID000150305
Drug	toxiusol diacetate	POLA1 POLN	3.86e-05	2	142	2	CID000475566
Drug	chrysene-5,6-oxide	POLA1 POLN	3.86e-05	2	142	2	CID000027062
Drug	5-N3dUMP	POLA1 POLN	3.86e-05	2	142	2	CID003036471
Drug	5-N3dUTP	POLA1 POLN	3.86e-05	2	142	2	CID003035898
Drug	4'-fluoro-4-aminobiphenyl	POLA1 POLN	3.86e-05	2	142	2	CID000009462
Drug	mannan	ESRRB CAPN3 OLFM1 PYGB PYGM	4.62e-05	63	142	5	CID000000870
Drug	vitamin B	FMO3 RB1 PSMC4 MCM7 AASDH XRCC4 ME1 USP7 SERPIND1	1.01e-04	295	142	9	CID000000936
Drug	1-oleoyl-2-acetylglycerol	TRPC7 TRPC3 TRPC6	1.02e-04	15	142	3	ctd:C038237
Drug	Gvapspat amide	RYR3 PYGB PYGM	1.02e-04	15	142	3	CID000125015
Drug	4-nitrophenylmaltoheptaoside	CAPN3 PYGB PYGM	1.02e-04	15	142	3	CID000173254
Drug	sotolon	ACO1 PYGB PYGM	1.02e-04	15	142	3	CID000062835
Drug	maltoheptose	CAPN3 MYCBP PYGB PYGM	1.11e-04	40	142	4	CID003037125
Drug	3,5-dimethylphenyl isocyanate	PYGB PYGM	1.15e-04	3	142	2	CID000521488
Drug	butylanilinouracil	POLA1 POLN	1.15e-04	3	142	2	CID003080854
Drug	3-deaza-2'-deoxyadenosine	POLA1 POLN	1.15e-04	3	142	2	CID000122636
Drug	azidoglycerol	POLA1 POLN	1.15e-04	3	142	2	CID000108212
Drug	5'-deoxy-5'-fluoro-5'-(methylthio)adenosine	PYGB PYGM	1.15e-04	3	142	2	CID000147839
Drug	BiodUTP	POLA1 POLN	1.15e-04	3	142	2	CID006438561
Drug	AC1LDLIB	POLA1 POLN	1.15e-04	3	142	2	CID000620682
Drug	baumycins	POLA1 POLN	1.15e-04	3	142	2	CID000125122
Drug	NSC758405	PYGB PYGM	1.15e-04	3	142	2	CID000003201
Drug	3,5-dinitrophenyl phosphate	PYGB PYGM	1.15e-04	3	142	2	CID000151920
Drug	pyridoxal phosphoglucose	PYGB PYGM	1.15e-04	3	142	2	CID000196007
Drug	5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone	PYGB PYGM	1.15e-04	3	142	2	CID000093111
Drug	adenosine-5'-chloromethylphosphonate	PYGB PYGM	1.15e-04	3	142	2	CID000191554
Drug	hydan	PYGB PYGM	1.15e-04	3	142	2	CID000008360
Drug	EHMF	PYGB PYGM	1.15e-04	3	142	2	CID000033931
Drug	pyridoxal 5'-methylenephosphonate	PYGB PYGM	1.15e-04	3	142	2	CID003082249
Drug	Plp 5'-mpa	PYGB PYGM	1.15e-04	3	142	2	CID003082151
Drug	glucose-1,2-cyclic phosphate	PYGB PYGM	1.15e-04	3	142	2	CID000191723
Drug	3'-FFdUrd	PYGB PYGM	1.15e-04	3	142	2	CID000072260
Drug	2',3',4',5,5'-pentachloro-2-biphenylol	PYGB PYGM	1.15e-04	3	142	2	CID000119518
Drug	AC1L8XK3	PYGB PYGM	1.15e-04	3	142	2	CID000409735
Drug	N-acetyl-N'-beta-D-glucopyranosyl urea	PYGB PYGM	1.15e-04	3	142	2	CID000446801
Drug	riboflavin tetraacetate	PYGB PYGM	1.15e-04	3	142	2	CID000094186
Drug	5-hydroxymethylchrysene sulfate	POLA1 POLN	1.15e-04	3	142	2	CID000058130
Drug	2,5-dimethyl-3-furanone	PYGB PYGM	1.15e-04	3	142	2	CID000085730
Drug	3,5-dinitrophenol	PYGB PYGM	1.15e-04	3	142	2	CID000011459
Drug	deoxyribose 5-phosphate	POLA1 PYGB PYGM POLN	1.23e-04	41	142	4	CID000000635
Drug	Biliton	DNAH3 DYNLL1 DNAH5 DYNC1H1	1.23e-04	41	142	4	CID000002974
Drug	thymidine glycol	POLA1 OLFM1 POLN	1.25e-04	16	142	3	CID003035041
Drug	homonojirimycin	CAPN3 PYGB PYGM	1.51e-04	17	142	3	CID000159496
Drug	4-amino-2,6-dinitrotoluene	CYP8B1 SPTAN1 PSMC4 MCM7 ATP8B2 USP14 XRN1 USP7 CSTF3 DYNLL1 DDX24 DDX39B	1.52e-04	541	142	12	ctd:C035207
Drug	5-bromouracil	POLA1 ACO1 RECQL5 POLN	1.77e-04	45	142	4	CID000005802
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	CEP290 DAB2 SCYL2 CEP350 AGFG1 DDX24 RAD21	1.82e-04	188	142	7	6735_DN
Drug	Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A	SYNE1 DAB2 XRCC4 IFIH1 FIG4 PIP4K2A ELK3	2.01e-04	191	142	7	7376_DN
Drug	KB-R7943	TRPC7 SYNE1 TRPC6 RYR3	2.10e-04	47	142	4	CID004534086
Drug	radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A	UBR2 TRPC3 KHDRBS2 XRCC4 USP7 MAPRE2 CDH6	2.14e-04	193	142	7	6938_UP
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; MCF7; HT_HG-U133A	GDAP1 STAT1 ITPK1 SCYL2 AGFG1 TOP3A CCDC93	2.14e-04	193	142	7	3209_DN
Drug	Sulfaphenazole [526-08-9]; Down 200; 12.8uM; HL60; HT_HG-U133A	CAPN3 XRCC4 STAT1 CENPQ SCYL2 IFIH1 PYGB	2.28e-04	195	142	7	1836_DN
Drug	Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A	RB1 CAPN3 CEP290 CEP350 PYGB DDX24 CDH6	2.28e-04	195	142	7	6159_DN
Drug	galocitabine	PYGB PYGM	2.30e-04	4	142	2	CID000065950
Drug	5-deoxyribose-1-phosphate	PYGB PYGM	2.30e-04	4	142	2	CID000135786
Drug	ingliforib	PYGB PYGM	2.30e-04	4	142	2	CID006451325
Drug	uric acid riboside	PYGB PYGM	2.30e-04	4	142	2	CID000164933
Drug	dimethylformamide dimethylacetal	ACO1 SYNE1	2.30e-04	4	142	2	CID000078373
Drug	pseudo-dl-glucose	PYGB PYGM	2.30e-04	4	142	2	CID000125259
Drug	dCTPalphaS	POLA1 POLN	2.30e-04	4	142	2	CID000125113
Drug	pyridoxal diphosphate	PYGB PYGM	2.30e-04	4	142	2	CID000125696
Drug	5-pyrimidinol	POLA1 POLN	2.30e-04	4	142	2	CID000565855
Drug	6-nitrobenzimidazole	POLA1 POLN	2.30e-04	4	142	2	CID000007195
Drug	2,5-anhydro-D-mannitol 1-phosphate	PYGB PYGM	2.30e-04	4	142	2	CID000189134
Drug	AC1LAMW2	PYGB PYGM	2.30e-04	4	142	2	CID000491364
Drug	FdUrd-C8	PYGB PYGM	2.30e-04	4	142	2	CID000094262
Drug	glycovir	CAPN3 TG	2.30e-04	4	142	2	CID000060807
Drug	5-(3-aminopropyl)-2'-deoxyuridine	POLA1 POLN	2.30e-04	4	142	2	CID003081165
Drug	Mem-CC	PYGB PYGM	2.30e-04	4	142	2	CID003081269
Drug	BCIp4A	PYGB PYGM	2.30e-04	4	142	2	CID000192417
Drug	DHdTTP	POLA1 POLN	2.30e-04	4	142	2	CID000129184
Drug	dTTP-GLY	POLA1 POLN	2.30e-04	4	142	2	CID000129192
Drug	3'-chloromethotrexate	PYGB PYGM	2.30e-04	4	142	2	CID000097703
Drug	dahCTP	POLA1 POLN	2.30e-04	4	142	2	CID000194866
Drug	Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; HL60; HT_HG-U133A	RB1 TAF1B TRMT2B ATP8B2 USP14 RECQL5 PYGB	2.35e-04	196	142	7	6155_DN
Drug	Hesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A	SPTAN1 STAT1 RABGAP1L RECQL5 USP7 RNF24 CDH6	2.35e-04	196	142	7	1531_DN
Drug	Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	DNAH3 SPTAN1 XRCC4 STAT1 IFIH1 CDH6 CCDC93	2.42e-04	197	142	7	6011_DN
Drug	Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A	STAT1 ITPK1 RABGAP1L RECQL5 CDH6 TOP3A CCDC93	2.42e-04	197	142	7	6012_DN
Drug	Tocainide hydrochloride; Down 200; 17.4uM; HL60; HT_HG-U133A	MCMBP SYNE1 XRCC4 RABGAP1L AGFG1 PYGB MAPRE2	2.42e-04	197	142	7	2931_DN
Drug	Doxepin hydrochloride [1229-29-4]; Down 200; 12.6uM; HL60; HT_HG-U133A	DNAH3 MCMBP ARHGAP10 CAPN3 ATP8B2 PIP4K2A TOP3A	2.42e-04	197	142	7	2384_DN
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A	ARHGAP10 SYNE1 SPTAN1 TAF1B XRCC4 RECQL5 CUZD1	2.50e-04	198	142	7	4551_DN
Drug	Trolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A	MCMBP ARHGAP10 SPTAN1 ATP8B2 RECQL5 SYNE2 PIP4K2A	2.58e-04	199	142	7	2883_DN
Drug	AC1L3XPY	OLFM1 PYGB PYGM	2.91e-04	21	142	3	CID000124005
Drug	I0329	CAPN3 PYGB PYGM	2.91e-04	21	142	3	CID000439668
Drug	Pro-phe-arg-mca	ME1 TG KNG1	3.35e-04	22	142	3	CID000174085
Drug	maltosaccharide	CAPN3 PYGB PYGM	3.35e-04	22	142	3	CID005461034
Drug	pargyline	AASDH PHF21A DYNLL1 ELK3 DYNC1H1	3.58e-04	97	142	5	CID000004688
Drug	heptulose-2-P	PYGB PYGM	3.82e-04	5	142	2	CID000124823
Drug	6-FPLP	PYGB PYGM	3.82e-04	5	142	2	CID000146246
Disease	n-acetylglucosamine-6-sulfatase measurement	CFH RASSF5 RASSF3	3.49e-07	4	132	3	EFO_0020586
Disease	proteinuria (biomarker_via_orthology)	CFH TRPC6 HAVCR1	1.03e-05	10	132	3	DOID:576 (biomarker_via_orthology)
Disease	nicotine dependence (implicated_via_orthology)	TRPC7 TRPC3 TRPC6	1.87e-05	12	132	3	DOID:0050742 (implicated_via_orthology)
Disease	skin barrier function measurement	FCN1 OLFM1	1.99e-05	2	132	2	EFO_0007891
Disease	myeloid white cell count	UBR2 CYP8B1 TRPC6 IFIH1 PPP1R8 RASSF5 HAVCR1 FCN1 SUPV3L1 RABGAP1L TTC29 OLFM1 ADGRF5 RASSF3 MAPRE2	2.05e-05	937	132	15	EFO_0007988
Disease	bcl-2-like protein 2 measurement	CFH KNG1	5.94e-05	3	132	2	EFO_0021928
Disease	X-linked mental retardation with cerebellar hypoplasia and distinctive facial appearance (implicated_via_orthology)	ARHGAP42 ARHGAP10	1.18e-04	4	132	2	DOID:0080311 (implicated_via_orthology)
Disease	Autosomal dominant Emery-Dreifuss muscular dystrophy	SYNE1 SYNE2	1.18e-04	4	132	2	cv:CN293514
Disease	Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder)	SYNE1 SYNE2	1.97e-04	5	132	2	C0410190
Disease	Autosomal Recessive Emery-Dreifuss Muscular Dystrophy	SYNE1 SYNE2	1.97e-04	5	132	2	C1450051
Disease	NKG2-D type II integral membrane protein measurement	CFH KLRK1	1.97e-04	5	132	2	EFO_0008250
Disease	lysophosphatidylcholine acyltransferase 2 measurement	CFH KNG1	1.97e-04	5	132	2	EFO_0801775
Disease	stimulant use measurement	RB1 ASAP1 DYNLL1	2.64e-04	28	132	3	EFO_0600076
Disease	Emery-Dreifuss muscular dystrophy	SYNE1 SYNE2	2.94e-04	6	132	2	cv:C0410189
Disease	Muscular Dystrophy, Emery-Dreifuss	SYNE1 SYNE2	2.94e-04	6	132	2	C0410189
Disease	ficolin-1 measurement	FCN1 OLFM1	2.94e-04	6	132	2	EFO_0008134
Disease	non-high density lipoprotein cholesterol measurement	MYO1H MIDEAS HAVCR1 RABGAP1L SYNE2 XRN1 DOCK7 AGFG1 PYGB ASCC3 MAPRE2	3.73e-04	713	132	11	EFO_0005689
Disease	FEV/FEC ratio	ARHGAP42 UTP6 SFRP2 KHDRBS2 MCM7 ASAP1 ITPK1 TG RASSF5 SYNE2 GNL2 DYNLL1 RASSF3 DNAH5 SPATA13	4.05e-04	1228	132	15	EFO_0004713
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	SYNE1 SYNE2	4.11e-04	7	132	2	C0751337
Disease	anosmin-1 measurement	CFH KNG1	4.11e-04	7	132	2	EFO_0802284
Disease	asymmetrical dimethylarginine measurement, serum dimethylarginine measurement	CACNA2D1 HAVCR1 PYGB	4.33e-04	33	132	3	EFO_0005418, EFO_0006522
Disease	neurodegenerative disease (implicated_via_orthology)	UBR2 PSMC4 FIG4 PNPLA7 DYNC1H1	5.01e-04	145	132	5	DOID:1289 (implicated_via_orthology)
Disease	emphysema imaging measurement	TRPC3 CCDC18 FAM135B DYNLL1 DNAH5	5.17e-04	146	132	5	EFO_0007626
Disease	influenza A (H1N1)	CEP290 PIP4K2A AGFG1 TEKT1	6.39e-04	87	132	4	EFO_1001488
Disease	mean platelet volume	COL6A6 MYO5A POLA1 TRPC3 ASAP1 ADH4 RASSF5 SYNE2 DOCK7 USP7 ADGRF5 RASSF3 DDX39B	6.76e-04	1020	132	13	EFO_0004584
Disease	Charcot-Marie-Tooth disease	GDAP1 FIG4 DYNC1H1	8.84e-04	42	132	3	cv:C0007959
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	MYO1H CAPN3 HAVCR1 SYNE2 DOCK7	9.23e-04	166	132	5	EFO_0004530, EFO_0004611
Disease	hereditary spastic paraplegia (implicated_via_orthology)	CAPN3 PSMC4 PNPLA7	9.47e-04	43	132	3	DOID:2476 (implicated_via_orthology)
Disease	triglycerides in large LDL measurement	HAVCR1 SYNE2 DOCK7	9.47e-04	43	132	3	EFO_0022319
Disease	corpus callosum volume measurement	CACNA2D1 LRRC49 TG PPP1R9B	1.08e-03	100	132	4	EFO_0010299
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	SYNE1 SYNE2	1.27e-03	12	132	2	DOID:11726 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth Disease	GDAP1 FIG4	1.27e-03	12	132	2	C0007959
Disease	level of Phosphatidylinositol (16:0_18:1) in blood serum	DOCK7 USP7	1.27e-03	12	132	2	OBA_2045152
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	MYO1H CAPN3 HAVCR1 DOCK7	1.34e-03	106	132	4	EFO_0008317, EFO_0008596
Disease	glycerophospholipid measurement	SYNE2 DOCK7 PYGB	1.39e-03	49	132	3	EFO_0007630
Disease	Charcot-Marie-Tooth disease type 4	GDAP1 FIG4	1.50e-03	13	132	2	cv:C4082197
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	MYO1H CAPN3 HAVCR1 DOCK7	1.53e-03	110	132	4	EFO_0008317, EFO_0008591, EFO_0008596
Disease	triglyceride measurement, intermediate density lipoprotein measurement	CAPN3 HAVCR1 SYNE2 DOCK7	1.58e-03	111	132	4	EFO_0004530, EFO_0008595
Disease	B-cell acute lymphoblastic leukemia	PIP4K2A ELK3	2.01e-03	15	132	2	EFO_0000094
Disease	triglycerides in LDL measurement	HAVCR1 SYNE2 DOCK7	2.04e-03	56	132	3	EFO_0022320
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	CAPN3 ADH4 KNG1	2.04e-03	56	132	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	immature platelet measurement	ASAP1 RASSF5 PPP1R9B RASSF3	2.04e-03	119	132	4	EFO_0803541
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	MYO1H CAPN3 HAVCR1 SYNE2 DOCK7	2.10e-03	200	132	5	EFO_0004611, EFO_0020945
Disease	C-X-C motif chemokine 6 measurement	CFH CLK2	2.29e-03	16	132	2	EFO_0008059
Disease	muscular dystrophy (is_implicated_in)	SYNE1 CAPN3	2.58e-03	17	132	2	DOID:9884 (is_implicated_in)
Disease	Charcot-Marie-Tooth disease type 2	GDAP1 DYNC1H1	2.58e-03	17	132	2	cv:C0270914
Disease	Adrenocortical carcinoma	RB1 DAXX	2.90e-03	18	132	2	C0206686
Disease	Headache	CACNA2D1 MYO1H RNF213	2.99e-03	64	132	3	HP_0002315
Disease	apolipoprotein B measurement	CACNA2D1 MIDEAS HAVCR1 FIG4 SYNE2 DOCK7 PYGB MAPRE2 CCDC93	3.04e-03	663	132	9	EFO_0004615
Disease	Malignant neoplasm of breast	SFRP2 RB1 SYNE1 SPTAN1 STAT1 SGK3 TMTC4 MAGED2 SYNE2 ANKRD30A ELK3 VPS13B	3.25e-03	1074	132	12	C0006142
Disease	histidine measurement	TRPC3 KCNIP4 KNG1	3.26e-03	66	132	3	EFO_0009769
Disease	fatty acid measurement	UBR2 MYO1H CAPN3 PHF21A HAVCR1 DOCK7 KCNIP4	3.55e-03	436	132	7	EFO_0005110
Disease	energy expenditure measurement	CACNA2D1 USP7	3.58e-03	20	132	2	EFO_0008005
Disease	neutrophil count	UBR2 CYP8B1 PCDHA10 IFIH1 RASSF5 HAVCR1 ERAP2 FCN1 CLK2 RABGAP1L OLFM1 ADGRF5 RASSF3 MAPRE2	3.63e-03	1382	132	14	EFO_0004833
Disease	Sarcoma	RB1 PRAME	3.94e-03	21	132	2	C1261473
Disease	severe acute respiratory syndrome, COVID-19	CACNA2D1 TRPC7 GDAP1 TG RASSF5 KCNIP4 RASSF3	4.07e-03	447	132	7	EFO_0000694, MONDO_0100096
Disease	nephrosis (biomarker_via_orthology)	CFH HAVCR1	4.33e-03	22	132	2	DOID:2527 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
KYLKDIKIVKETNAA	ANKRD20A1	541	Q5TYW2
DEEKLKYIKKYLQAV	ACO1	326	P21399
KVLEDKIIQEYKKFR	ELL3	346	Q9HB65
KEKEEIQYHLNFLKK	CENPQ	101	Q7L2Z9
KYLKDIKIVKETNAA	ANKRD20A8P	541	Q5CZ79
EVVKSKLSKEYNFIK	CPED1	956	A4D0V7
KLVTDYKNKKFNLDA	ADH4	336	P08319
ALKIIKNVEKYKEAA	CLK2	191	P49760
YVKLKDNEKNRKLFD	DDX39B	266	Q13838
KYLKDIKIVKETNAA	ANKRD20A4P	541	Q4UJ75
KYFEDIKILKEKNAE	ANKRD30A	1131	Q9BXX3
LKYILVEKKQINKFK	AASDH	106	Q4L235
QNLEKKYLKDFEIVK	ANKRD36	1531	A6QL64
DRKKDQYKVGEVLKF	CFH	581	P08603
KDISYLISNKKEAKF	DBF4	81	Q9UBU7
KKCYKLENEKLFEEF	DAXX	56	Q9UER7
LQKAQVVELVKKYKK	ATP8B2	811	P98198
QFLESFLQKYKKIKD	POLN	706	Q7Z5Q5
LKRVKDIGYIFKEKF	RB1	416	P06400
NIDLKFKIIVTAYKD	RB1	716	P06400
KQAAAKFYSFLVLKK	RAD21L1	516	Q9H4I0
KEEIKEKVHKYNLAV	RASSF3	51	Q86WH2
QKKYDKFRQKLEEAL	RASSF5	396	Q8WWW0
KQAAAKFYSFLVLKK	RAD21	591	O60216
IYFTKNLKNLAEKAK	PARP9	736	Q8IXQ6
KFKKKAYQAIEERQS	MPEG1	681	Q2M385
KFKLEKNYNLVESLK	SERPIND1	396	P05546
KYLKDIKIVKETNAA	ANKRD20A2P	541	Q5SQ80
KKKFDKETEKNYSLI	ARHGAP10	131	A1A4S6
DLKDLFQVIYNVKKK	DAB2	161	P98082
FQVIYNVKKKEEEKK	DAB2	166	P98082
VIKALDEKIAKYQKF	GNL2	596	Q13823
DEKIAKYQKFLDKAK	GNL2	601	Q13823
KEKNLLKYIQFKTFV	FMO3	96	P31513
EKKIKKLNFQAFAEL	ITPK1	16	Q13572
LKIAEKIVKDAYQEK	ME1	511	P48163
DVKKLITDEFVKQKY	MAGED2	411	Q9UNF1
KEFQSFKKYLARKIL	NLRP11	21	P59045
LLKEKLKAYEEQKAF	KIF18A	386	Q8NI77
FVVLKKDVDAAYLNK	KRT4	241	P19013
KYNIEKDIAAHIKKE	DYNLL1	31	P63167
KFEAQQYKLKVEKQL	NEK5	411	Q6P3R8
QKYKAKKGVKFEINL	NEK5	571	Q6P3R8
YKADAKLVLQFKEEV	OLFM1	171	Q99784
KVYSKEDQDLLKLVK	KLRK1	136	P26718
IKAKNYDKVEKLFQR	CSTF3	76	Q12996
NVKYLKKILDELEKV	GDAP1	201	Q8TB36
KFTKKELQILYRGFK	KCNIP4	81	Q6PIL6
LKIYDCLQEFKEKKL	MPP4	66	Q96JB8
IAYKAAKEEEKQKLL	PHF21A	556	Q96BD5
IKEKKKFCKTYIEDL	LRRC49	621	Q8IUZ0
YEAIVEENKKLKAKL	MYCBP	76	Q99417
YAFKEVIEKKNVKVE	POLA1	596	P09884
KAKKQVFYGEEERLK	PNPLA7	311	Q6ZV29
IYKVVQFKQKLKASE	LRRC70	546	Q7Z2Q7
YALEKEKVKKFLQEF	MCM7	6	P33993
EKKVDELVKFLSVKY	MAGEA13P	106	A6NCF6
FYFKLKQGIEKKVVI	RABGAP1L	301	Q5R372
YFVLDIINKKDKDKF	PCDHA10	176	Q9Y5I2
LKKFCKKDYAVQVAV	NTN3	456	O00634
KSFKVADEAEKYKLV	FCN1	221	O00602
KYLKDIKIVKETNAA	ANKRD20A3P	541	Q5VUR7
KQRLYFKTVKEFKEE	CCDC93	601	Q567U6
IFASLALYDVKEKKK	DOCK7	281	Q96N67
ALYDVKEKKKISENF	DOCK7	286	Q96N67
KEKKKISENFYFDLN	DOCK7	291	Q96N67
LAENVKIKIDKFKQY	DNAH3	926	Q8TD57
EELSKAFQQYKKKVA	CCDC18	246	Q5T9S5
AFQQYKKKVAEKLEK	CCDC18	251	Q5T9S5
EIFNKYNKDKKVRVF	CACNA2D1	371	P54289
DLKYNYKEEVKKNIL	CEP290	2426	O15078
ENKYKILEKEFQQFK	CEP120	791	Q8N960
LKKLIVKKFHKYEEE	FIG4	656	Q92562
KELYIVRENKALQKK	IFIH1	936	Q9BYX4
QEESKFKRKKYIFQL	CCDC160	56	A6NGH7
AEKELLHYKKEIFTK	CCDC160	171	A6NGH7
ELYRKQKEAFTKVKN	CEP350	631	Q5VT06
KTADKLKQYIEKLAA	ASAP1	256	Q9ULH1
IIKKVIGQKFVYKFV	ELK3	71	P41970
LKKVKFQAKLEHEYI	MAPRE2	101	Q15555
AERKLFNKGIAIYKK	MIDEAS	836	Q6PJG2
VINFKKIYKTLKKDE	DDX24	696	Q9GZR7
EEKFQKGIIQYLKKF	ERAP2	471	Q6P179
LKRKIKQFEKQVELY	DYNC1H1	1176	Q14204
EKKYLDVISNKNIKL	KHDRBS2	46	Q5VWX1
KDLFKAVDAALKKYN	KNG1	31	P01042
VKKLLDFEKKKVYTL	CDH6	331	P55285
VEKDYKIKLNFKEIF	CUZD1	186	Q86UP6
YKKLKVEKEEFVTLK	ESRRB	331	O95718
YQAKEKFKKELKIEG	FAM135B	1096	Q49AJ0
FEQLHKKCLEKKVLY	CAPN3	61	P20807
RKLDGKFYAVKVLQK	SGK3	181	Q96BR1
EDVLQKAKFFQDKKY	COL6A6	2211	A6NMZ7
KLDFGQYAKKLVLKV	CYP8B1	96	Q9UNU6
ATIKKKEYNFLDQRK	DNAH5	516	Q8TE73
YIDDNNKKVFLEKLK	PIP4K2A	246	P48426
KVIEYFKEKLKENNA	MCMBP	31	Q9BTE3
KAIIKKASDLEYKIQ	UTP6	31	Q9NYH9
KNDFALKIKVKEITY	SFRP2	191	Q96HF1
YEEQLKVKFAAQKKI	TRMT2B	96	Q96GJ1
YNLKVKVLFDKDVNE	STAT1	356	P42224
AKKLKKLFEAQEKLY	CARS1	721	P49589
AKDFEKAYKTVIKKD	PSMC4	396	P43686
KLIEKLIIDEKKYYL	PPP1R8	36	Q12972
LFSYLIEKVKRKKNV	PRAME	191	P78395
VALAKDKFYKVQEAI	SYNE1	4656	Q8NF91
KSLAKYLKAVEELKN	SYNE2	891	Q8WXH0
YLDKIKKFIASIEKE	SYNE2	2556	Q8WXH0
YVFKIQEVQEKKKFE	ARHGAP42	181	A6NI28
VSLVEKKLFEKKYSV	TAF1B	561	Q53T94
LGVIIAKKYFFKKEV	HAVCR1	311	Q96D42
AKKYFFKKEVQQLSV	HAVCR1	316	Q96D42
VAVFVFDKKLIDKYQ	SCYL2	61	Q6P3W7
EFYAYKQVILKEKVK	RNF24	56	Q9Y225
SAKYNLEKDLKDKFV	TEKT1	166	Q969V4
NEVKKVLDKFYKRKE	SUPV3L1	91	Q8IYB8
VLDKFYKRKEIQKLG	SUPV3L1	96	Q8IYB8
KLILDIFEYECKKKI	ADGRF5	351	Q8IZF2
QKVKEFLQEKYEKKR	AGFG1	111	P52594
EYFLALKKQVISKEA	ASCC3	1236	Q8N3C0
AVILVHDIKKDFYKK	ASCC3	1701	Q8N3C0
AKVANLYKASVLKKV	RECQL5	591	O94762
DIYKFQRKFLKDLEK	SPATA13	291	Q96N96
VKDYIQEYLTLLKKK	RNF213	4146	Q63HN8
QKYKESEALFLKAIK	TMTC4	666	Q5T4D3
YKIARQLTEKAIKEK	TTLL8	41	A6PVC2
AKVKQENKLKFAAYL	PYGM	536	P11217
DKFVKRKVINKYGDL	RYR3	4551	Q15413
DLLKKQVATYSFKDK	STPG4	106	Q8N801
KKKQEALVARYEALK	SPTAN1	756	Q13813
LYKRFILVLNEKKTK	XRCC4	176	Q13426
ENKLKFSAFLEKEYK	PYGB	541	P11216
VAAEEARNYKEKKKL	XRN1	376	Q8IZH2
KQVLKYYKQVIKIKE	TTC41P	1011	Q6P2S7
ELLYKSFKVKKEDFK	SLU7	351	O95391
VIKKYLLKVAELFEK	SNX5	261	Q9Y5X3
QKYKQVFIEAVAKAK	TOP3A	611	Q13472
LAKKKYELQLTQEKI	TSGA10	221	Q9BZW7
ENKEYKQAIKILIKA	TTC29	246	Q8NA56
TEAIKYLKKFVKIAR	TTC29	331	Q8NA56
NKELEEYKEKCFIKL	VPS13B	3491	Q7Z7G8
IAAKIKGQAYFKIKE	TARBP1	1006	Q13395
VLANIEKEFKNDYKK	TRPC6	306	Q9Y210
LKLAIKYEVKKFVAH	TRPC6	366	Q9Y210
RNYIKEKKAAVKEFE	SUDS3	126	Q9H7L9
FFYKEKESVNAKVLK	USP14	331	P54578
DLKYKKLFAVRFAKN	UBR2	381	Q8IWV8
TFYDIKKNKKLILDF	TIGD7	41	Q6NT04
LVENKKYFKRSELAK	PRPF18	21	Q99633
FRKKVILEDKVKNFY	TG	1951	P01266
EEKVKYTVFKVLKNS	USP7	586	Q93009
KLEYEYALKIQKLKE	ZFC3H1	971	O60293
RVKLAIKYEVKKFVA	TRPC3	296	Q13507
IKLAIKYEVKKFVAH	TRPC7	311	Q9HCX4
ELAKIKQKIEYSALK	MYO1H	921	Q8N1T3
LEKLILDKDKYQFGK	MYO5A	731	Q9Y4I1
LIKDYQQKEIEFLKK	PPP1R9B	761	Q96SB3